ASAveterinary attended the ESVD-ECVD congress in Lille, a premier European event dedicated to veterinary dermatology that brought together approximately 1,400 professionals.
Two distinct yet complementary approaches took centre stage: MLS® Laser Therapy with M-VET, focused on photobiomodulation, and Blazeris®, the new veterinary surgical laser developed by ASA.
Dermatology and photobiomodulation: focusing on skin tissue
The skin is a key area where photobiomodulation offers promising application potential.
The interaction between light and biological tissues can modulate cellular processes involved in inflammatory responses and tissue repair.
For veterinarians, these mechanisms make laser therapy a particularly attractive tool for managing skin lesions and wound healing as part of a multimodal clinical approach.
For instance, a recent case series described the use of MLS® Laser Therapy with M-VET® as an adjunctive treatment for skin wounds in three different avian species: a peregrine falcon, a barn owl, and a lovebird. The authors observed lesion improvement following the introduction of laser therapy into the treatment protocol, as well as good treatment tolerability; they identified PBM as a promising supplementary strategy for wound healing, while also highlighting the need for further studies.
From treatment to surgery: needs identified by specialists
Discussions with dermatologists in Lille highlighted another area of keen interest: the use of lasers in dermatological surgery.
In particular, attention focused on anatomical areas and conditions where precision and control during the surgical procedure are paramount. Key topics included pathologies of the ear canal, as well as procedures on the extremities and paws, including interdigital lesions and cysts.
These are contexts where anatomical accessibility, the need to operate on small, delicate areas, and tissue management make the development of specialised instruments particularly valuable.
This is the setting for Blazeris®, the new ASA technology developed specifically for veterinary soft-tissue surgery.
Blazeris®: bringing laser technology into dermatological surgery
Blazeris® introduces a 445 nm laser source to veterinary surgery, designed to interact effectively with tissue chromophores and to facilitate precise, controlled surgical manoeuvres.
The ability to combine incision and haemostasis makes this technology particularly attractive for procedures where a clear surgical field and high precision are critical.
Two technologies, two goals, one clinical field
The experience in Lille highlighted just how diverse the applications of “lasers in veterinary dermatology” have now become.
On the one hand, MLS® photobiomodulation can be integrated into the treatment plan to modulate inflammation and tissue repair processes. On the other, Blazeris® applies laser energy directly to the surgical procedure, focusing on incision, haemostasis, and operational precision.
Not alternative technologies, therefore, but tools with different purposes that expand the possibilities available to veterinary professionals.
Discover the ASAveterinary laser technologies designed for veterinary practice.